ANTHONY TRINH, 123Herbals LLC recalls SILINTAN 25/pills
- Published
- 11 Mar 2026
- Units affected
- N/A
- Agency
- FDA
- Country
- United States
The hazard
Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.
Classification: Class I — the most serious type: there is a reasonable chance this product could cause serious health problems or death.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China
- Brand / company
- ANTHONY TRINH, 123Herbals LLC
- Codes / lots
- All lots within expiry
- Distribution
- USA nationwide
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 11 Mar 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.